Literature DB >> 19953116

Cavernous malformations: natural history, diagnosis and treatment.

Sachin Batra1, Doris Lin, Pablo F Recinos, Jun Zhang, Daniele Rigamonti.   

Abstract

Cavernous malformations (CMs) consist of dilated vascular channels that have a characteristic appearance on MRI. CMs are usually found intracranially, although such lesions can also affect the spinal cord. Individuals with CMs can present with epilepsy and focal neurological deficits or acute intracranial hemorrhage. In many cases, however, patients with such lesions are asymptomatic at diagnosis. Furthermore, several natural history studies have documented that a substantial proportion of asymptomatic CMs follow a benign course. Surgical resection is recommended for CMs that require intervention. Radiosurgery has been advocated for many lesions that have not been easily accessible by conventional surgery. The outcomes of radiosurgery and surgery for deep lesions, however, vary widely between studies, rendering treatment recommendations for such CMs difficult to make. In addition to reviewing the literature, this article will discuss the current understanding of lesion pathophysiology and explore the controversial issues in the management of CMs, such as when to use radiosurgery or surgery in deep-seated lesions, the treatment of epilepsy, and the safety of anticoagulation.

Entities:  

Mesh:

Year:  2009        PMID: 19953116     DOI: 10.1038/nrneurol.2009.177

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  119 in total

1.  Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases.

Authors:  A Churchyard; M Khangure; K Grainger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 2.  Cryptic vascular malformations: controversies in terminology, diagnosis, pathophysiology, and treatment.

Authors:  W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  1997 Nov-Dec       Impact factor: 3.825

Review 3.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].

Authors:  P Otten; G P Pizzolato; B Rilliet; J Berney
Journal:  Neurochirurgie       Date:  1989       Impact factor: 1.553

4.  Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy. Case report.

Authors:  Eugenio Pozzati; Mino Zucchelli; Anna Federica Marliani; Luca Albini Riccioli
Journal:  Neurosurg Focus       Date:  2006-07-15       Impact factor: 4.047

5.  Sorting nexin 17, a non-self-assembling and a PtdIns(3)P high class affinity protein, interacts with the cerebral cavernous malformation related protein KRIT1.

Authors:  Martin Czubayko; Peter Knauth; Thomas Schlüter; Volker Florian; Ralf Bohnensack
Journal:  Biochem Biophys Res Commun       Date:  2006-05-02       Impact factor: 3.575

6.  Magnetoencephalography (MEG) predicts focal epileptogenicity in cavernomas.

Authors:  H Stefan; G Scheler; C Hummel; J Walter; J Romstöck; M Buchfelder; I Blümcke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 7.  Cavernous malformations of the brain stem. A review of 139 cases.

Authors:  J A Fritschi; H J Reulen; R F Spetzler; J M Zabramski
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients.

Authors:  Ioannis Stavrou; Christoph Baumgartner; Josa M Frischer; Siegfried Trattnig; Engelbert Knosp
Journal:  Neurosurgery       Date:  2008-11       Impact factor: 4.654

9.  Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis.

Authors:  Floriana Francalanci; Maria Avolio; Elisa De Luca; Dario Longo; Valeria Menchise; Paolo Guazzi; Francesco Sgrò; Marco Marino; Luca Goitre; Fiorella Balzac; Lorenza Trabalzini; Saverio Francesco Retta
Journal:  Exp Cell Res       Date:  2008-10-21       Impact factor: 3.905

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more
  67 in total

Review 1.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

2.  Angiographic detection of cerebral cavernous malformations with C-arm cone beam CT imaging in three patients.

Authors:  Martin G Radvany; Daniele Rigamonti; Philippe Gailloud
Journal:  BMJ Case Rep       Date:  2013-05-22

3.  CCM1/KRIT1 mutation in monozygotic twins of a polyzygotic triplet birth: genetic, clinical and radiological characteristics.

Authors:  Karl Hartmann; Klaus-Peter Stein; Belal Neyazi; Ute Felbor; Sven Hethey; I Erol Sandalcioglu
Journal:  Neurosurg Rev       Date:  2019-06-06       Impact factor: 3.042

Review 4.  Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

Authors:  P Dammann; C Schaller; U Sure
Journal:  Neurosurg Rev       Date:  2016-11-08       Impact factor: 3.042

5.  Cavernous malformation of the optic pathway mimicking optic glioma: a case report.

Authors:  Yui Mano; Toshihiro Kumabe; Ryuta Saito; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2014-07-03       Impact factor: 1.475

6.  Ultra-high-resolution C-arm flat-detector CT angiography evaluation reveals 3-fold higher association rate for sporadic intracranial cavernous malformations and developmental venous anomalies: a retrospective study in consecutive 58 patients with 60 cavernous malformations.

Authors:  Burak Kocak; Osman Kizilkilic; Buge Oz; Dogu Vuralli Bakkaloglu; Cihan Isler; Naci Kocer; Civan Islak
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

7.  Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish.

Authors:  Jing Lin; Jie Liang; Jun Wen; Man Luo; Jiaoxing Li; Xunsha Sun; Xiaowei Xu; Jianli Li; Dongxian Wang; Jie Wang; Huimin Chen; Rong Lai; Fengyin Liang; Chuan Li; Fei Ye; Jingjing Zhang; Jinsheng Zeng; Shulan Yang; Wenli Sheng
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-04       Impact factor: 6.200

Review 8.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.

Authors:  Bryan T Richardson; Christopher F Dibble; Asya L Borikova; Gary L Johnson
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

9.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

10.  Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.

Authors:  Romuald Girard; Hussein A Zeineddine; Courtney Orsbon; Huan Tan; Thomas Moore; Nick Hobson; Robert Shenkar; Rhonda Lightle; Changbin Shi; Maged D Fam; Ying Cao; Le Shen; April I Neander; Autumn Rorrer; Carol Gallione; Alan T Tang; Mark L Kahn; Douglas A Marchuk; Zhe-Xi Luo; Issam A Awad
Journal:  J Neurosci Methods       Date:  2016-06-23       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.